BYSI Stock Summary and Trading Ideas (Beyondspring - | NASDAQ:BYSI)

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform. It has a scalable business model integrating clinical resources in the United States and China.

Beyondspring - trades on the NASDAQ stock market under the symbol BYSI.

As of April 23, 2024, BYSI stock price climbed to $2.27 with 107,097 million shares trading.

BYSI has a beta of 0.94, meaning it tends to be less sensitive to market movements. BYSI has a correlation of 0.01 to the broad based SPY ETF.

BYSI has a market cap of $88.85 million. This is considered a Micro Cap stock.

In the last 3 years, BYSI stock traded as high as $33.00 and as low as $.54.

The top ETF exchange traded funds that BYSI belongs to (by Net Assets): IWC.

BYSI has outperformed the market in the last year with a return of +110.2%, while the SPY ETF gained +24.2%. In the last 3 month period, BYSI beat the market returning +162.1%, while SPY returned +4.8%. However, in the most recent 2 weeks BYSI has underperformed the stock market by returning -11.3%, while SPY returned -2.6%.

BYSI support price is $1.93 and resistance is $2.29 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BYSI stock will trade within this expected range on the day.